Skip to main content
BMJ Case Reports logoLink to BMJ Case Reports
. 2017 Oct 13;2017:bcr2017220779. doi: 10.1136/bcr-2017-220779

Disfiguring facial pyoderma vegetans with an excellent outcome

James Keitley 1, Liezel Griffin 1,2, Luisa Motta 2, Janice Ferguson 2, Helen Young 1,2
PMCID: PMC5652482  PMID: 29030376

Abstract

We describe a case of disfiguring facial pyoderma vegetans in order to highlight the challenges in managing this rare skin condition and review the literature.

A 54-year-old woman presented to dermatology clinic with a 3-month history of a left-sided facial lesion, which had been treated as an infected sebaceous cyst. The lesion had dramatically increased in size in the weeks prior to presentation. There was a history of Crohn’s disease and ileal adenocarcinoma, both of which were in remission. A clinical diagnosis of pyoderma vegetans was made and the patient responded well to immunosuppressive therapy with oral ciclosporin. Carbon dioxide (CO2) laser resurfacing to residual scarring contributed to an excellent cosmetic result.

Keywords: Dermatology, Contraindications And Precautions, Malignant Disease And Immunosuppression, Skin, Medical Management

Background

Pyoderma vegetans (PV) is a rare inflammatory skin disease, presenting with large, persistent, vesiculopustular exudative plaques with well-defined borders.1 Reported here is a case of PV, which illustrates the challenges of diagnosis and management of a rare dermatological condition alongside the need to balance risks and potential benefits of treatment for patients with complex healthcare needs.

Our patient experienced a rapid progression of her facial lesion prior to referral, thus highlighting the importance of clinical re-evaluation in apparently straightforward cases behaving atypically. The significant psychological burden resulting from skin disease is also evidenced.

Unusually, this case of PV occurred in a woman with inactive Crohn’s disease and against a background of previous ileal adenocarcinoma. Treatment of PV is often difficult, with delayed diagnosis and unsatisfactory outcomes reported in the literature.1 Despite the relative risks associated with treatment, our patient achieved an excellent outcome.

Case presentation

A 54-year-old woman presented with a 3-month history of a large, left-sided facial lesion (figure 1). It had been treated in primary care as an ‘infected sebaceous cyst’ but had failed to respond to multiple courses of oral antibiotics and had rapidly enlarged in the weeks before presentation. She had a 20-year history of Crohn’s disease that had been quiescent for a number of years, ileal adenocarcinoma 7 years previously, congestive cardiac failure and severe chronic obstructive pulmonary disease, which restricted her mobility. There was a family history of inflammatory bowel disease.

Figure 1.

Figure 1

Skin appearances at presentation to the dermatology clinic.

She lived with her husband and was a carer for their disabled child. She described periods of low mood and had become self-conscious about her facial disfigurement to the extent that she was virtually housebound.

On examination, there was a large, tumid plaque of coalescing papulopustular lesions on the left cheek. The raised, vegetative surface had a cobblestone-like appearance and a well-circumscribed border (figure 1). The surrounding facial skin was normal.

Investigations

A transient peripheral blood eosinophilia (0.5×109/L) was noted at the time of presentation.

An incisional skin biopsy was performed and showed a severe inflammatory process with abscess formation. The epidermis was acanthotic, spongiotic and featured exocytosis of lymphocytes. There were numerous intraepithelial neutrophils. Eosinophilic spongiosis was not a feature. Dense mixed—predominantly acute—inflammatory changes were abundant within the dermis and there were sinus tracts lined with histiocytes. Well-defined granulomas were not identified. Relatively scanty intradermal eosinophils were present. There were intraepithelial abscesses within eccrine glands. There was no evidence of vasculitis or malignancy. Stains for fungi, bacteria and mycobacteria were negative (figure 2).

Figure 2.

Figure 2

Micrograph of skin biopsy demonstrating neutrophils in an eccrine duct. Magnification x20.

Skin swabs taken for bacteriology cultured normal skin flora and coliforms.

A chest, abdomen and pelvis CT scan, performed to exclude recurrence of ileal adenocarcinoma or Crohn’s disease, was normal with the exception of renal artery stenosis as an incidental finding. Renal function was normal.

Based on clinical features and histological findings, a diagnosis of PV was made.

Differential diagnosis

  • Pyoderma vegetans

  • Cutaneous Crohn’s disease

  • Botryomycosis

  • Pyoderma gangrenosum

  • Pemphigus vegetans

Treatment

Our patient was initially treated with oral prednisolone 30 mg/day and lymecycline 408 mg/day in addition to topical therapy with betamethasone with clioquinol. The clinical response to treatment was encouraging. Following histology review, her topical treatment was intensified to 0.3% tacrolimus in clobetasol 17-propionate ointment, which resulted in additional improvement (figure 3).

Figure 3.

Figure 3

Treatment of pyoderma vegetans with topical therapies resulted in an encouraging clinical response.

When our investigations confirmed that there was no recurrence of ileal adenocarcinoma or Crohn’s disease and that despite renal artery stenosis her renal function was normal, oral ciclosporin at a dose of 4 mg/kg/day was started. There was an excellent response to treatment and the ciclosporin dose was gradually reduced to 2 mg/kg. Remission was achieved after 8 months and ciclosporin was stopped.

However, despite resolution of PV, our patient was left with significant skin texture change, warty excrescences, scarring and telangiectasia that were a focus of considerable distress for her (figure 4).

Figure 4.

Figure 4

Following treatment with ciclosporin, the lesion of pyoderma vegetans had resolved leaving an atrophic macular scarred area on the patient’s left cheek, which had cobblestone lesions peripherally and an island of verrucous tissue centrally. There was no evidence of residual inflammation within the skin.

Although we were concerned that her PV could Koebnerise (skin disease recurring at the site of trauma), due to the impact of the patient’s facial appearance on her quality of life, a referral to the dermatology laser team was made. Following assessment, carbon dioxide (CO2) laser resurfacing was considered, and after a successful test patch, she underwent resurfacing of the area of residual scarring on her left cheek (figure 5).

Figure 5.

Figure 5

Skin appearances at discharge demonstrating a good result to a combination of topical, systemic and laser treatments.

Outcome and follow-up

Following an excellent cosmetic result from laser resurfacing, we observed a significant improvement in our patient’s mood. There was no evidence of Koebnerisation or recurrent disease activity during follow-up for 4 years after initial presentation, at which time point she was discharged.

Discussion

PV is a rare, chronic vegetative skin disease first described in 1898 by Hallopeau.2 PV most commonly affects intertriginous areas, the face, oral mucosa and scalp3–5 where erythematous cutaneous papulopustular lesions rapidly coalesce into raised vegetative plaques with well-circumscribed borders. The condition usually presents between 20 and 50 years of age and has a 3:1 male predominance.4 6 The pathogenesis and aetiology are incompletely understood, although bacterial colonisation in immunosuppressive states has been described.1 3 PV has been most frequently associated with ulcerative colitis (UC),5–16 and disease activity is an influential factor with presentation of PV often occurring during flares of UC.5 12 In contrast, PV is less commonly associated with Crohn’s disease11 17–23 where it can occur during phases of low or absent Crohn’s disease activity.24 PV can be associated with lymphoproliferative disorders, alcoholism, HIV and immunosuppressive therapy.1 It has also been described in immunocompetent and apparently healthy individuals.3 The presentation of our case was unusual in several respects, namely a female patient with quiescent Crohn’s disease. In addition, although the oral variant of PV has been associated with adenocarcinoma in one case report,8 to the best of our knowledge, our case is the first to describe cutaneous PV presenting in a patient with a previous history of adenocarcinoma.

Diagnosis of PV can be challenging and it usually depends on differentiating it from other chronic, vegetative dermatoses such as cutaneous Crohn’s disease and botryomycosis. Cutaneous Crohn’s disease can cause erythema, ulceration and cobble stoning, commonly of the face or oral cavity.12 Botryomycosis results from bacterial infection usually with Staphylococcus aureus and presents variably—commonly with ulceration, nodulation and fissuring, which is not associated with inflammatory bowel disease.25 Immunobullous disorders, such as pemphigus vegetans, are characterised by deposits of IgG and complement on direct immunofluorescence.26 PV may also closely resemble pyoderma gangrenosum (PG), an ulcerating neutrophilic dermatosis associated with inflammatory bowel disease in 30% of cases.27 There are no diagnostic histological features for PG, but a perivascular lymphocytic infiltrate and vasculitic changes to the ulcer edge are commonly seen.27

There is considerable debate in the literature whether PV and PG are variants of the same disease although there are also well-documented differences, which suggest that they are distinct entities per se. In contrast to PV, cases of PG do not appear to closely correlate with inflammatory bowel disease activity.28 Large case series have reported that eosinophilia on histopathology, and to a lesser extent peripheral eosinophilia, may be helpful in distinguishing PV from PG.28 Notably, our patient had a transient peripheral blood eosinophilia at the time of presentation, which in conjunction with the pattern of clinical features supported the diagnosis of PV. We also observed no Koebnerisation of our patient’s lesion following CO2 laser resurfacing, which, in contrast to PG, is in keeping with other reports in the literature where multiple biopsies have been taken from lesions of PV without extension or induction of new lesion formation.

PV is a rare entity that may or may not be a variant of PG, pemphigus vegetans or pyodermatitis vegetans. In addition, nomenclature has been unclear; pyostomatitis vegetans has been used to describe oral lesions and pyodermatitis–pyostomatitis vegetans termed a separate entity.3 As with many rare disorders, a clear therapeutic strategy is not well defined. In the literature, PV has most commonly been treated with steroids, either topical, oral or both,1 4 8–11 15 16 19 21 23 29 30 and immunosuppressive treatments, such as ciclosporin, have shown promising results.4 17 Oral tetracyclines have demonstrated utility in the management of PG due to their inhibition of inflammation and dermal destruction, and these were therefore successfully incorporated into the management plan of our patient.31 Anti-tissue necrosis factor biologic agents have been used successfully,1 17 32 and in UC-associated PV, colectomy can lead to remission.8 15 33 34

Our case highlights the importance of careful clinical and histological evaluation in an apparently straightforward case and the requirement for clinicians to consider the patient holistically when designing a management plan. Our case also illustrates successful treatment outcome as a consequence of teamwork across a network of specialist dermatology services including medical dermatology, dermatopathology and laser dermatology.

Learning points.

  • This case highlights the importance of careful clinical, supported by histological, evaluation in apparently straightforward cases. Be prepared to reconsider an initial diagnosis if there is no improvement.

  • The risks of treatment must be carefully balanced against the potential benefits of treatment on a case-by-case basis.

  • The psychological impact of dermatological diseases cannot be overestimated. Many common dermatological diseases, although not life threatening per se, can be devastating and life ruining for sufferers.

  • Management of dermatological conditions are complex and present diagnostic and treatment challenges to the clinician.

Footnotes

Handling editor: Seema Biswas

Contributors: JK, LG, LM, JF and HY designed, wrote and approved the manuscript.

Competing interests: None declared.

Patient consent: Obtained.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1.Carrera C, Mascaró JM, Moreno-Romero JA, et al. Pyoderma vegetans associated with severe psoriatic arthritis: good response to etanercept. Dermatology 2007;214:77–81. 10.1159/000096917 [DOI] [PubMed] [Google Scholar]
  • 2.Hallopeau M. Pyodermite Vegetante, ihre Beziehungen zur Dermatitisherpetiformis und dem Pemphigus vegetans. Archiv für Dermatologie und Syphilis 1898;19:77–88. [Google Scholar]
  • 3.Adişen E, Tezel F, Gürer MA. Pyoderma vegetans: a case for discussion. Acta Derm Venereol 2009;89:186–8. 10.2340/00015555-0602 [DOI] [PubMed] [Google Scholar]
  • 4.Brinkmeier T, Frosch PJ. Pyodermatitis-pyostomatitis vegetans: a clinical course of two decades with response to cyclosporine and low-dose prednisolone. Acta Derm Venereol 2001;81:134–6. [DOI] [PubMed] [Google Scholar]
  • 5.Hegarty AM, Barrett AW, Scully C, et al. Pyostomatitis vegetans. Clinical and experimental dermatology 2004;29:1–7. 10.1111/j.1365-2230.2004.01438.x [DOI] [PubMed] [Google Scholar]
  • 6.Wolz MM, Camilleri MJ, McEvoy MT, et al. Pemphigus vegetans variant of IgA pemphigus, a variant of IgA pemphigus and other autoimmune blistering disorders. Am J Dermatopathol 2013;35:e53–e56. 10.1097/DAD.0b013e318278d419 [DOI] [PubMed] [Google Scholar]
  • 7.Bianchi L, Carrozzo AM, Orlandi A, et al. Pyoderma vegetans and ulcerative colitis. Br J Dermatol 2001;144:1224–7. 10.1046/j.1365-2133.2001.04237.x [DOI] [PubMed] [Google Scholar]
  • 8.Calobrisi SD, Mutasim DF, McDonald JS. Pyostomatitis vegetans associated with ulcerative colitis. Temporary clearance with fluocinonide gel and complete remission after colectomy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;79:452–4. [DOI] [PubMed] [Google Scholar]
  • 9.Canpolat F, Cemil BÇ, Yılmazer D, et al. Pyoderma vegetans associated with ulcerative colitis: a case with good response to steroids. Case Rep Dermatol 2011;3:80–4. 10.1159/000327221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Chaudhry SI, Philpot NS, Odell EW, et al. Pyostomatitis vegetans associated with asymptomatic ulcerative colitis: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:327–30. 10.1016/S1079-2104(99)70217-9 [DOI] [PubMed] [Google Scholar]
  • 11.Hansen LS, Silverman S, Daniels TE. The differential diagnosis of pyostomatitis vegetans and its relation to bowel disease. Oral Surg Oral Med Oral Pathol 1983;55:363–73. 10.1016/0030-4220(83)90191-3 [DOI] [PubMed] [Google Scholar]
  • 12.Katsanos KH, Torres J, Roda G, et al. Review article: non-malignant oral manifestations in inflammatory bowel diseases. Aliment Pharmacol Ther 2015;42:40–60. 10.1111/apt.13217 [DOI] [PubMed] [Google Scholar]
  • 13.Lobkowicz F, Eckert F, Braun-Falco O, et al. A specific marker of Crohn disease and ulcerative colitis. Der Hautarzt 1991;42:92–5. [PubMed] [Google Scholar]
  • 14.Markiewicz M, Suresh L, Margarone J, et al. Pyostomatitis vegetans: a clinical marker of silent ulcerative colitis. J Oral Maxillofac Surg 2007;65:346–8. 10.1016/j.joms.2005.07.020 [DOI] [PubMed] [Google Scholar]
  • 15.Ruiz-Roca JA, Berini-Aytés L, Gay-Escoda C, et al. Pyostomatitis vegetans. Report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:447–54. 10.1016/j.tripleo.2003.08.022 [DOI] [PubMed] [Google Scholar]
  • 16.Soriano ML, Martínez N, Grilli R, et al. Pyodermatitis-pyostomatitis vegetans: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:322–6. 10.1016/S1079-2104(99)70216-7 [DOI] [PubMed] [Google Scholar]
  • 17.Bens G, Laharie D, Beylot-Barry M, et al. Successful treatment with infliximab and methotrexate of pyostomatitis vegetans associated with Crohn’s disease. Br J Dermatol 2003;149:181–4. 10.1046/j.1365-2133.2003.05385.x [DOI] [PubMed] [Google Scholar]
  • 18.Delaporte E, Viget N, Pasturel-Michon U, et al. Pyostomatitis-pyodermatitis vegetans uncovering a case of Crohn disease. Ann Dermatol Venereol 1998;125:331–4. [PubMed] [Google Scholar]
  • 19.Ficarra G, Cicchi P, Amorosi A, et al. Oral Crohn’s disease and pyostomatitis vegetans: an unusual association. Oral Surg Oral Med Oral Pathol 1993;75:220–4. [DOI] [PubMed] [Google Scholar]
  • 20.Merkourea SS, Tosios KI, Merkoureas S, et al. Pyostomatitis vegetans leading to Crohn’s disease diagnosis. Ann Gastroenterol 2013;26:1–2. [PMC free article] [PubMed] [Google Scholar]
  • 21.Neville BW, Smith SE, Maize JC, et al. Pyostomatitis vegetans. Am J Dermatopathol 1985;7:69–78. [DOI] [PubMed] [Google Scholar]
  • 22.Oettinger R, Gerner P, Börner N, et al. Pyostomatitis vegetans and Crohn’s disease. A specific association of 2 diseases. Dtsch Med Wochenschr 1998;123:285–8. 10.1055/s-2007-1023950 [DOI] [PubMed] [Google Scholar]
  • 23.Yorulmaz A, Yalçın B, İ G, et al. A case of pyoderma vegetans associated with Crohn’s disease showing good response to prednisolone. Turkish Journal of Geriatrics 2015;18:167–70. [Google Scholar]
  • 24.Storwick GS, Prihoda MB, Fulton RJ, et al. Pyodermatitis-pyostomatitis vegetans: a specific marker for inflammatory bowel disease. J Am Acad Dermatol 1994;31(2 Pt):336–41. 10.1016/S0190-9622(94)70167-9 [DOI] [PubMed] [Google Scholar]
  • 25.Bonifaz A, Carrasco E. Botryomycosis. Int J Dermatol 1996;35:381–8. 10.1111/j.1365-4362.1996.tb03015.x [DOI] [PubMed] [Google Scholar]
  • 26.Mehravaran M, Kemény L, Husz S, et al. Pyodermatitis-pyostomatitis vegetans. Br J Dermatol 1997;137:266–9. 10.1046/j.1365-2133.1997.18181914.x [DOI] [PubMed] [Google Scholar]
  • 27.Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. BMJ 2006;333:181–4. 10.1136/bmj.333.7560.181 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Clark LG, Tolkachjov SN, Bridges AG, et al. Pyostomatitis vegetans (PSV)-pyodermatitis vegetans (PDV): a clinicopathologic study of 7 cases at a tertiary referral center. J Am Acad Dermatol 2016;75:578–84. 10.1016/j.jaad.2016.03.047 [DOI] [PubMed] [Google Scholar]
  • 29.Ayangco L, Rogers RS, Sheridan PJ. Pyostomatitis vegetans as an early sign of reactivation of Crohn’s disease: a case report. J Periodontol 2002;73:1512–6. 10.1902/jop.2002.73.12.1512 [DOI] [PubMed] [Google Scholar]
  • 30.Uzunçakmak TK, Akdeniz N, Karadağ AS, et al. Pyodermatitis vegetans after total colectomy. Indian Dermatol Online J 2015;6:9–S11. 10.4103/2229-5178.171052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Monk E, Shalita A, Siegel DM. Clinical applications of non-antimicrobial tetracyclines in dermatology. Pharmacol Res 2011;63:130–45. 10.1016/j.phrs.2010.10.007 [DOI] [PubMed] [Google Scholar]
  • 32.Mijandrusić-Sincić B, Licul V, Gorup L, et al. Pyostomatitis vegetans associated with inflammatory bowel disease—report of two cases. Coll Antropol 2010;34(Suppl 2):279–82. [PubMed] [Google Scholar]
  • 33.VanHale HM, Rogers RS, Zone JJ, et al. Pyostomatitis vegetans. a reactive mucosal marker for inflammatory disease of the gut. Arch Dermatol 1985;121:94–8. [DOI] [PubMed] [Google Scholar]
  • 34.Yasuda M, Amano H, Nagai Y, et al. Pyodermatitis-pyostomatitis vegetans associated with ulcerative colitis: successful treatment with total colectomy and topical tacrolimus. Dermatology 2008;217:146–8. 10.1159/000135708 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Case Reports are provided here courtesy of BMJ Publishing Group

RESOURCES